Why Idexx Laboratories Stock Surged by Almost 15% Today

Group 1 - Idexx Laboratories' stock surged nearly 15% following the release of its strong quarterly earnings, significantly outperforming the S&P 500 index which gained only 0.2% [1] - The company reported third-quarter revenue of approximately $1.11 billion, a 13% increase from the same period in 2024, and net income rose 18% to $274.6 million [2][3] - Idexx's adjusted net income per share increased by 15% to $3.22, surpassing analyst estimates for both revenue and adjusted profitability [3] Group 2 - Management raised guidance for full-year 2025, projecting revenue between $4.27 billion and $4.3 billion, and earnings per share (EPS) of $12.81 to $13.01, both exceeding average analyst estimates [4] - The CEO highlighted the company's exceptional progress in innovation-driven growth and strong global customer adoption as key factors for the solid growth [3][6]